Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Fertil Steril. 2019 Apr;111(4):763–771. doi: 10.1016/j.fertnstert.2018.12.016

Table 2.

Participant characteristics and self-reported perceived fertility potential

Participant Characteristics More/As fertile n (%) n=210 Less fertile n (%) n=179 Infertile n (%) n=94 P-value
Current age (y)
 18 – 24 8 (3.9) 21 (11.9) 3 (3.3)
 25 – 30 44 (21.2) 41 (23.3) 23 (25.3) 0.001
 31 – 35 82 (39.4) 68 (38.6) 24 (26.4)
 36 – 41 74 (35.6) 46 (26.1) 41 (45.1)
Race
 White 158 (75.2) 132 (73.7) 70 (74.7)
 Black 6 (2.9) 1 (0.6) 3 (3.2) 0.39
 Asian/Pacific Islander 14 (6.7) 13 (7.3) 2 (2.1)
 Mixed/Other 32 (15.2) 33 (18.4) 19 (20.2)
Hispanic ethnicity 47 (22.3) 41 (22.9) 21 (22.3) 0.96
BMI (kg/m2)
 < 18.5 42 (20.9) 50 (28.3) 25 (26.9)
 18.5 – 24.9 98 (48.8) 73 (41.2) 41 (44.1) 0.75
 25 – 29.9 31 (15.4) 26 (14.7) 13 (14.0)
 ≥ 30 30 (14.9) 28 (15.8) 14 (15.1)
Education: college graduate 164 (78.1) 135 (75.4) 66 (70.2) 0.20
Income
 Less than $51,000 43 (20.5) 48 (26.8) 22 (23.4) 0.48
 Greater than $51,000 156 (74.3) 122 (68.2) 63 (67.0)
Current health insurance 201 (95.7) 169 (94.4) 90 (95.7) 0.84
Cancer Characteristics
Cancer category
 Breast 40 (19.1) 48 (26.8) 25 (26.6)
 Leukemia/Lymphoma 63 (30.0) 59 (33.0) 31 (33.0)
 Gynecologic†† 10 (4.8) 7 (3.9) 11 (11.7) 0.02
 Gastrointestinal††† 5 (2.4) 6 (3.4) 3 (3.2)
 Bone/soft tissue 14 (6.7) 12 (6.7) 7 (7.5)
 Thyroid, Skin 78 (37.1) 47 (26.3) 17 (18.1)
Chemotherapy 109 (51.9) 121 (67.6) 74 (78.7) <0.001
Bone Marrow Transplant 1 (0.5) 4 (2.2) 10 (10.6) <0.001
Surgical cancer therapy 150 (71.4) 124 (69.3) 58 (61.7) 0.16
Radiation 99 (47.1) 87 (48.6) 49 (52.1) 0.65
Age at cancer diagnosis
 Less than 18 25 (12.0) 20 (11.4) 8 (8.8)
 18 – 24 74 (35.6) 61 (34.7) 28 (30.8) 0.34
 25 – 35 109 (52.4) 95 (53.9) 55 (60.4)
Years since cancer diagnosis
 < 2 19 (9.1) 30 (16.8) 15 (16.0)
 2 – 5 41 (19.5) 55 (30.7) 27 (28.7) 0.002
 ≥ 5 150 (71.4) 94 (52.5) 52 (55.3)
Reproductive Characteristics
History of infertility 11 (5.2) 28 (15.6) 23 (24.5) <0.001
 Prior to cancer diagnosis 6 (2.9) 14 (7.8) 13 (13.8) <0.001
 After cancer diagnosis 5 (2.4) 19 (10.6) 15 (15.9)
Menses within the last year
 0 – 3 38 (18.1) 33 (18.4) 37 (39.4)
 4 – 9 32 (15.2) 32 (17.9) 18 (19.2) <0.001
 10 – 12 140 (66.7) 114 (63.7) 39 (41.5)
Menses within the last year*
 0 – 3 17 (13.7) 14 (14.4) 31 (40.3)
 4 – 9 15 (12.1) 14 (14.4) 11 (14.3) <0.001
 10 – 12 92 (74.2) 69 (71.2) 35 (45.4)
Ever pregnant 142 (67.6) 72 (40.2) 43 (45.7) <0.001
Times pregnant
 1 31 (21.8) 29 (40.3) 10 (23.2) 0.03
 2 65 (45.8) 22 (30.5) 15 (34.9)
 ≥ 3 46 (32.4) 21 (29.2) 18 (41.9)
Ever live birth 129 (61.4) 57 (31.8) 39 (41.5) <0.001
Recent intercourse** 192 (91.4) 153 (85.5) 81 (83.2) 0.15

Data missing for some variables

††

Gynecologic cancer = cervix, uterus, ovary

†††

Gastrointestinal cancer = pancreas, gallbladder, stomach, small intestine, colon, appendix, rectum

*

Excluding participants on birth control pills, depot medroxyprogesterone, implant, IUD, contraceptive patch and contraceptive ring

**

Recent intercourse indicates heterosexual intercourse within 3 months of completing the enrollment questionnaire